NO973656D0 - Farmasöytisk blanding for parenteral anvendelse inneholdende en indolkarboksylsyre - Google Patents

Farmasöytisk blanding for parenteral anvendelse inneholdende en indolkarboksylsyre

Info

Publication number
NO973656D0
NO973656D0 NO973656A NO973656A NO973656D0 NO 973656 D0 NO973656 D0 NO 973656D0 NO 973656 A NO973656 A NO 973656A NO 973656 A NO973656 A NO 973656A NO 973656 D0 NO973656 D0 NO 973656D0
Authority
NO
Norway
Prior art keywords
carboxylic acid
pharmaceutical composition
parenteral use
use containing
indole carboxylic
Prior art date
Application number
NO973656A
Other languages
English (en)
Other versions
NO973656L (no
Inventor
Andrea Lodi
Maria Teresa Rossato
Original Assignee
Glaxo Wellcome Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa
Publication of NO973656D0 publication Critical patent/NO973656D0/no
Publication of NO973656L publication Critical patent/NO973656L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO973656A 1995-02-11 1997-08-08 Farmasöytisk blanding for parenteral anvendelse inneholdende en indolkarboksylsyre NO973656L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9502695.1A GB9502695D0 (en) 1995-02-11 1995-02-11 Pharmaceutical composition
PCT/EP1996/000515 WO1996024376A1 (en) 1995-02-11 1996-02-08 Pharmaceutical composition for parenteral application containing an indole-carboxylic acid

Publications (2)

Publication Number Publication Date
NO973656D0 true NO973656D0 (no) 1997-08-08
NO973656L NO973656L (no) 1997-10-08

Family

ID=10769456

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973656A NO973656L (no) 1995-02-11 1997-08-08 Farmasöytisk blanding for parenteral anvendelse inneholdende en indolkarboksylsyre

Country Status (18)

Country Link
US (2) US5886018A (no)
EP (1) EP0809514A1 (no)
JP (1) JPH10513464A (no)
KR (1) KR19980702109A (no)
AU (1) AU707220B2 (no)
BR (1) BR9607433A (no)
CA (1) CA2212041A1 (no)
CZ (1) CZ252897A3 (no)
EA (1) EA000211B1 (no)
FI (1) FI973280A0 (no)
GB (1) GB9502695D0 (no)
HU (1) HUP9702448A2 (no)
IL (1) IL117098A0 (no)
NO (1) NO973656L (no)
NZ (1) NZ300937A (no)
PL (1) PL321734A1 (no)
WO (1) WO1996024376A1 (no)
ZA (1) ZA961051B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
WO2003039540A2 (en) * 2001-11-09 2003-05-15 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
US20040019075A1 (en) * 2002-05-29 2004-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg New formulation for the parenteral application of crobenetine
CZ2006427A3 (cs) 2003-12-29 2006-11-15 Sepracor Inc. Pyrrolové a pyrazolové inhibitory DAAO
US8809393B2 (en) 2005-02-01 2014-08-19 Troikaa Pharmaceuticals Ltd Injectable preparations of diclofenac and its pharmaceutically acceptable salts
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
AU2018284335A1 (en) 2017-06-12 2020-01-30 Glytech Llc. Treatment of depression with NMDA antagonists and D2/5HT2A or selective 5HT2A antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0347123A (ja) * 1989-05-05 1991-02-28 G D Searle & Co インドール―２―カルボキシレート化合物類を含有するｃｎｓ疾患治療用組成物
WO1992001670A1 (en) * 1990-07-16 1992-02-06 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition

Also Published As

Publication number Publication date
PL321734A1 (en) 1997-12-22
NO973656L (no) 1997-10-08
CA2212041A1 (en) 1996-08-15
KR19980702109A (ko) 1998-07-15
IL117098A0 (en) 1996-06-18
JPH10513464A (ja) 1998-12-22
WO1996024376A1 (en) 1996-08-15
AU4622896A (en) 1996-08-27
HUP9702448A2 (hu) 1999-10-28
US5886018A (en) 1999-03-23
EP0809514A1 (en) 1997-12-03
AU707220B2 (en) 1999-07-08
BR9607433A (pt) 1998-05-26
FI973280A (fi) 1997-08-08
EA199700095A1 (ru) 1998-02-26
US6020359A (en) 2000-02-01
MX9706044A (es) 1998-06-28
NZ300937A (en) 1999-02-25
CZ252897A3 (cs) 1998-03-18
EA000211B1 (ru) 1998-12-24
ZA961051B (en) 1996-09-11
GB9502695D0 (en) 1995-03-29
FI973280A0 (fi) 1997-08-08

Similar Documents

Publication Publication Date Title
FI944800A (fi) Indoli-2-karboksyylihappojohdannaisia
ATE211131T1 (de) Arylsulfonylaminohydroxamsäurederivate
FI973518A (fi) Farmaseuttinen koostumus piperidinoalkanoliyhdisteille
NO982331D0 (no) Kinolin-derivater
AU3952693A (en) Indole derivatives as 5-HT1-like agonists
NO961475D0 (no) Indol-derivater
NO308236B1 (no) Farmasøytisk blanding inneholdende indolderivater
EE03744B1 (et) Valproehapet sisaldavad farmatseutilised mikrokerakesed oraalseks manustamiseks
NO973656D0 (no) Farmasöytisk blanding for parenteral anvendelse inneholdende en indolkarboksylsyre
FI960634A0 (fi) Uusia kinolonikarboksyylihappojohdannaisia
NO975296L (no) Fremgangsmåte for fremstilling av karboksylsyrederivater
FI953361A (fi) Menetelmä substituoitujen indolonijohdannaisten valmistamiseksi
BR9610139A (pt) Derivado de ácido carboxílico
ATE193701T1 (de) Substituierte indol-derivate
HU9602637D0 (en) 2-(4-pyrazolyloxy-pyrimidin-5-yl) acetic acid derivatives
DE69822338D1 (de) Polyisobuten substituierte bernsteinsäureimide
DK0876367T3 (da) Trans apovincaminsyreesterderivater som lægemidler
DE59605373D1 (de) Substituierte Indol-Derivate
SI0876367T1 (en) Trans apovincaminic acid ester derivatives as drugs
KR970020156U (ko) Tv용 간이 회전받침대
SE9504349D0 (sv) New amino acid derivatives
SE9502487D0 (sv) New amino acid derivatives
SE9502503D0 (sv) New amino acid derivatives
SE9502505D0 (sv) New amino acid derivatives
SE9503923D0 (sv) New amino acid derivatives